Neural Ice
Phase 2- Indications
- Osteoarthritis pain, Post-operative pain
Company intelligence / Profile preview
Brixton Biosciences
Cambridge, Massachusetts, United Statesbrixtonbio.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Brixton Biosciences has completed a first-in-human study of its Neural Ice™ injectable nerve block for knee osteoarthritis, achieving a 94% response rate in 16 patients. The company is now initiating pivotal randomized controlled trials for both chronic osteoarthritis knee pain and acute post-surgical knee replacement pain. The technology aims to provide non-addictive, drug-free, long-lasting local nerve blocks lasting several months from a single injection.
- Therapeutic areas
- RheumatologyNeurology
- Modalities
- DeviceNon-pharmacological therapy
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
1 asset03
Partnerships
None publicly disclosed; academic origin at Massachusetts General Brigham/Massachusetts General Hospital
Beyond the preview
Go deeper on Brixton Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Brixton Biosciences.